| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Sep 12, 2025 | Sep 15, 2025 | Rapport Therapeutics, Inc. | Director | Buy | 97.5 | +20,400 | 100.00% | ✗ | $499.4K |
| Jul 16, 2018 | Jul 18, 2018 | INCYTE CORP | EVP, Chief Scientific Officer | Sell | 46.3 | -448 | -1.28% | ✗ | $31.4K |
| Jul 5, 2018 | Jul 5, 2018 | INCYTE CORP | EVP, Chief Scientific Officer | Sell | 48.8 | -284 | -0.80% | ✗ | $19.4K |
| Feb 20, 2018 | Feb 22, 2018 | INCYTE CORP | EVP, Chief Scientific Officer | Sell | 26.3 | -3,022 | -7.91% | ✓ | $259K |
| Dec 1, 2017 | Dec 5, 2017 | INCYTE CORP | EVP, Chief Scientific Officer | Sell | 45.0 | -696 | -1.79% | ✓ | $68.2K |